Oestradiol Boosts Tumor Regression in Breast Cancer Treatment
Author Information
Author(s): Dabrosin C, Palmer K, Gauldie J
Primary Institution: McMaster University
Hypothesis
Does oestradiol enhance the immune response induced by adenoviral gene transfer in breast cancer?
Conclusion
Oestradiol supplementation significantly enhances tumor regression in a murine model of breast cancer when combined with adenoviral gene therapy.
Supporting Evidence
- Oestradiol-treated mice showed a 76% complete tumor regression rate compared to 18% in placebo-treated mice.
- All tumors in the E2-treated group showed either partial or total regression.
- Intratumoral IFN-γ levels were significantly higher in E2-treated mice compared to placebo.
Takeaway
This study shows that giving oestradiol to mice with breast cancer helps their bodies fight the cancer better when treated with a special virus.
Methodology
Ovariectomised mice were treated with oestradiol and injected with an adenoviral vector expressing B7-1/IL-2 to assess tumor regression and immune response.
Limitations
The study was conducted in a murine model, which may not fully replicate human responses.
Participant Demographics
FVB/n mice, 6–8 weeks old, ovariectomised.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website